Compliance With American Gastroenterological Association Inflammatory Bowel Disease Quality Measures

被引:0
|
作者
Feuerstein, Joseph D.
Lewandowski, Jeffrey
Martinez-Vazquez, Manuel
Leffler, Daniel
Cheifetz, Adam S.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1102
引用
收藏
页码:S374 / S375
页数:2
相关论文
共 50 条
  • [1] Compliance With American Gastroenterological Association Inflammatory Bowel Disease Quality Measures
    Siddique, Sana
    Feuerstein, Joseph
    Castillo, Natalia
    Lewandowski, Jeffrey
    Geissler, Kerry
    Vazquez, Manuel Martinez
    Leffler, Daniel
    Thukral, Bob
    Cheifetz, Adam
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S632 - S632
  • [2] Adherence to quality measures for inflammatory bowel disease in Korea: Questionnaire study based on American Gastroenterological Association Adult Inflammatory Bowel Disease Physician Performance Measures Set
    Song, H. K.
    Jung, S. -A.
    Cha, J. M.
    Hong, S. N.
    Seo, G. S.
    Lee, K. -M.
    Kim, Y. -H.
    Han, D. S.
    Yang, S. -K.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S304 - S305
  • [3] INFLAMMATORY BOWEL-DISEASE AND LYMPHOCYTOTOXIC ANTIBODY IN MEMBERS OF THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION
    GOODMAN, MJ
    STRICKLAND, RG
    KIRSNER, JB
    [J]. GASTROENTEROLOGY, 1979, 76 (05) : 1140 - 1140
  • [4] Documented Compliance with Inflammatory Bowel Disease Quality Measures Is Poor
    Joseph D. Feuerstein
    Jeffrey J. Lewandowski
    Manuel Martinez-Vazquez
    Daniel A. Leffler
    Adam S. Cheifetz
    [J]. Digestive Diseases and Sciences, 2015, 60 : 339 - 344
  • [5] INFLAMMATORY BOWEL-DISEASE AND LYMPHOCYTOTOXIC ANTIBODY IN MEMBERS OF AMERICAN GASTROENTEROLOGICAL ASSOCIATION
    GOODMAN, MJ
    STRICKLAND, RG
    KIRSNER, JB
    [J]. CLINICAL RESEARCH, 1978, 26 (05): : A662 - A662
  • [6] Documented Compliance with Inflammatory Bowel Disease Quality Measures Is Poor
    Feuerstein, Joseph D.
    Lewandowski, Jeffrey J.
    Martinez-Vazquez, Manuel
    Leffler, Daniel A.
    Cheifetz, Adam S.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (02) : 339 - 344
  • [7] American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
    Feuerstein, Joseph D.
    Nguyen, Geoffrey C.
    Kupfer, Sonia S.
    Falck-Ytter, Yngve
    Singh, Siddharth
    [J]. GASTROENTEROLOGY, 2017, 153 (03) : 827 - 834
  • [8] American Gastroenterological Association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease
    Lichtenstein, GR
    Abreu, MT
    Cohen, R
    Tremaine, W
    [J]. GASTROENTEROLOGY, 2006, 130 (03) : 940 - 987
  • [9] Re: American Gastroenterological Association Institute Guideline on therapeutic drug monitoring in inflammatory bowel disease
    Day, Andrew S.
    [J]. TRANSLATIONAL PEDIATRICS, 2018, 7 (01) : 11 - 13
  • [10] Quality Measures in Outpatient Inflammatory Bowel Disease Care: Are We Documenting Compliance?
    Wilson, Farra
    Bloomfeld, Richard
    Green, Patrick
    Dharod, Ajay
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S50 - S51